Scientific Overview
IGF-1 LR3 is a modified analog of human insulin-like growth factor 1 (IGF-1) used in research settings to evaluate IGF-1 receptor signaling and downstream pathway activation. In experimental models, IGF-1 LR3 is commonly used to study PI3K/Akt and MAPK/ERK signaling linked to cellular growth, differentiation, survival, and metabolic regulation.
Research Applications
-
IGF-1R activation and receptor signaling kinetics
-
Growth and differentiation assays in cell and tissue models
-
Anabolic signaling research and nutrient transport pathways
-
Tissue remodeling and repair mechanism studies
Molecular Information
-
Amino acid length: 83
-
Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA
-
Molecular formula: C400H625N111O115S9
-
Molecular weight: 9117.5 g/mol
-
CAS: 946870-92-4
-
PubChem: Substance record (SID) 381123731
Storage Instructions
This ezPeps product is supplied as a lyophilized (freeze dried) powdered form, which helps maintain stability during transit. When kept sealed and protected from heat and light, lyophilized products are generally stable for shipping and short term storage for up to 3 to 4 months.
After delivery, keep vials cold and away from light. If the product will be used within the next several weeks or months, refrigeration is generally acceptable. For longer term storage (several months to years), freezing is preferred to help preserve stability.
Once reconstituted, store refrigerated and use within 30 days.
____________________________________________________________
Intended Use
This product is intended strictly for in vitro research use. It is not approved for human or animal use and must not be used in food, drugs, supplements, or diagnostic procedures.
Legal Disclaimer
This product has not been evaluated by the FDA. No claims are made regarding diagnosis, treatment, cure, or prevention of disease. Use is restricted to qualified research professionals in appropriate laboratory settings.
Reviews
There are no reviews yet.